Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Günaj Rakipovski

Does Glucagon-Like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies

Current Diabetes Reviews
EndocrinologyMetabolismDiabetes
2016English

Related publications

Neuroprotective Mechanisms of Glucagon-Like Peptide-1-Based Therapies in Ischaemic Stroke: A Systematic Review Based on Pre-Clinical Studies

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Glucagon-Like Peptide-1 and Satiety

Nature
Multidisciplinary
1997English

Effects of Gastric Inhibitory Polypeptide, Glucagon-Like Peptide-1 and Glucagon-Like Peptide-1 Receptor Agonists on Bone Cell Metabolism

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Glucagon-Like Peptide-1 Does Not Have a Role in Hepatic Carbohydrate Metabolism

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1985English

Effect of Glucagon Like Peptide 1| (GLP1) Analogues on Obese Egyptians With and Without Diabetes

The Medical Journal of Cairo University
2019English

Impaired Cardiometabolic Responses to Glucagon-Like Peptide 1 in Obesity and Type 2 Diabetes Mellitus

Basic Research in Cardiology
Cardiovascular MedicinePhysiologyCardiology
2013English

Equine Glucagon-Like Peptide-1 Receptor Physiology

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies

Gastroenterology
HepatologyGastroenterology
2011English

Glucagon-Like Peptide-1 (7-37) Augments Insulin Release in Elderly Patients With Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy